Target intelligence / Profile preview

RNA, U6 small nuclear 752, pseudogene (RNU6-752P)

Target
RNU6-752P
Molecular classification
Other, Pseudogene, Small nuclear RNA pseudogene
01

Overview

RNU6-752P refers to a pseudogene of the U6 small nuclear RNA (snRNA) family, specifically the 752nd annotated locus. Pseudogenes are DNA sequences similar to functional genes but are typically non-functional due to accumulated mutations or lack of necessary regulatory elements[2][5]. The U6 snRNA, when functional, plays a critical role in the spliceosome, the molecular machine responsible for pre-mRNA splicing in eukaryotic cells[1][3]. However, as a pseudogene, RNU6-752P does not encode a functional RNA or protein and is not involved in the splicing reaction or any active cellular biochemical process. There is also no evidence that this particular pseudogene has a direct role in disease, functions as a biomarker, interacts with drugs, or is a therapeutic target. Its classification is strictly as a pseudogene, not a receptor, enzyme, or conventional drug target. Thus, it is not considered a biological therapeutic target, and there are no known mechanisms of action, disease roles, or safety concerns related to this locus[2][5].\n\nNotes: \n- No evidence that RNU6-752P is misspelled; the name is correct but the entity is not a functional or druggable target.\n- Pseudogenes can sometimes regulate gene expression via RNA-based mechanisms in specific cases, but there is no current evidence for such a function for RNU6-752P specifically[4]. \n- It is not a canonical therapeutic target such as a receptor, transporter, or enzyme but is part of genome annotation due to sequence similarity to functional U6 snRNA genes.

Other names
RNU6-752P
02

Biological functions

Other
03

Disease associations

Other

Beyond the preview

Go deeper on RNA, U6 small nuclear 752, pseudogene (RNU6-752P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 752, pseudogene (RNU6-752P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call